[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2019 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
29-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- 52.36%
YoY- 29.96%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 302,044 158,713 576,462 438,707 295,852 150,386 498,722 -28.43%
PBT 37,118 17,727 70,809 56,870 37,102 18,786 59,666 -27.14%
Tax -8,828 -4,166 -15,536 -13,630 -8,721 -4,321 -12,025 -18.63%
NP 28,290 13,561 55,273 43,240 28,381 14,465 47,641 -29.37%
-
NP to SH 28,290 13,561 55,273 43,240 28,381 14,465 47,641 -29.37%
-
Tax Rate 23.78% 23.50% 21.94% 23.97% 23.51% 23.00% 20.15% -
Total Cost 273,754 145,152 521,189 395,467 267,471 135,921 451,081 -28.34%
-
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div 3,421 - 40,937 6,745 6,618 - 36,403 -79.35%
Div Payout % 12.10% - 74.06% 15.60% 23.32% - 76.41% -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
NOSH 684,383 684,383 684,383 680,106 661,881 661,881 661,881 2.25%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 9.37% 8.54% 9.59% 9.86% 9.59% 9.62% 9.55% -
ROE 4.86% 2.51% 10.52% 8.55% 5.64% 2.91% 9.86% -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 44.13 23.19 84.49 65.04 44.70 22.72 75.35 -30.02%
EPS 4.13 1.98 8.25 6.49 4.26 2.19 7.26 -31.36%
DPS 0.50 0.00 6.00 1.00 1.00 0.00 5.50 -79.81%
NAPS 0.85 0.79 0.77 0.75 0.76 0.75 0.73 10.68%
Adjusted Per Share Value based on latest NOSH - 680,106
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 31.40 16.50 59.93 45.61 30.76 15.63 51.85 -28.44%
EPS 2.94 1.41 5.75 4.50 2.95 1.50 4.95 -29.36%
DPS 0.36 0.00 4.26 0.70 0.69 0.00 3.78 -79.17%
NAPS 0.6047 0.5621 0.5461 0.5259 0.5229 0.5161 0.5023 13.17%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 1.62 1.39 1.42 1.40 1.37 1.28 0.95 -
P/RPS 3.67 5.99 1.68 2.15 3.06 5.63 1.26 104.08%
P/EPS 39.19 70.15 17.53 21.84 31.95 58.57 13.20 106.70%
EY 2.55 1.43 5.70 4.58 3.13 1.71 7.58 -51.66%
DY 0.31 0.00 4.23 0.71 0.73 0.00 5.79 -85.81%
P/NAPS 1.91 1.76 1.84 1.87 1.80 1.71 1.30 29.26%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 13/08/20 18/05/20 13/02/20 29/11/19 30/08/19 21/05/19 18/02/19 -
Price 3.15 1.72 1.64 1.39 1.41 1.36 1.03 -
P/RPS 7.14 7.42 1.94 2.14 3.15 5.99 1.37 200.89%
P/EPS 76.20 86.80 20.24 21.68 32.88 62.23 14.31 205.24%
EY 1.31 1.15 4.94 4.61 3.04 1.61 6.99 -67.28%
DY 0.16 0.00 3.66 0.72 0.71 0.00 5.34 -90.37%
P/NAPS 3.71 2.18 2.13 1.85 1.86 1.81 1.41 90.70%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment